10 August 2017

Ideagen plc

("Ideagen" or the "Company")

Director Dealing

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that today Alan Carroll, a Non-Executive Director of the Company, sold 72,500 ordinary shares of 1 pence each ("Ordinary Shares") at a price of 80 pence per Ordinary Share and bought, into his SIPP, 72,500 Ordinary Shares at a price of 80.075 pence per Ordinary Share (the "Transfer").

Following the Transfer, Mr. Carroll's beneficial interest in the Company remains at 204,000 Ordinary Shares representing approximately 0.1% of the issued share capital of the Company.

About Ideagen plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in GRC (Governance, Risk and Compliance) and Content and Clinical solutions with a primary focus on organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete information lifecycle solutions that enable organisations to reduce risk, meet their regulatory and compliance standards, helping them to reduce costs and improve efficiency.

The Group has a customer base of over 3,000 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

For further information please visit www.ideagen.com